Anti-PD-1therapy Combined With Thermal Ablation for Advanced HCC
NCT03939975
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Carcinoma, Hepatocellular
Interventions
DRUG:
pembrolizumab or nivolumab or JS001
Sponsor
Sun Yat-sen University